Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02510417Phase 1Completed
Allogeneic Virus-specific T Cell Lines (VSTs)
Viral Infections After HSCT
PrincipalinvestigatorStart date: 2014-10-28
NCT02510404Phase 1Completed
Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Refractory Viral Infections
PrincipalinvestigatorStart date: 2014-04-01
NCT01945814Phase 1Completed
Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)
AdenovirusCMVEBV
PrincipalinvestigatorStart date: 2014-02-01
NCT02057445Phase 1Completed
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
Hodgkins LymphomaLymphoproliferative DisorderNon-Hodgkins Lymphoma
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mitchell Cairo, MD

New York Medical College

Similar
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinAdenoviridaeHodgkin Disease+2 more

Worked with same sponsors:

Baylor College of MedicineChildren's National Research Institute+7 more
Collaborated on 1 trial
Similarity Score54%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinHodgkin DiseaseHerpesvirus 4, Human+1 more

Worked with same sponsors:

Baylor College of MedicineM.D. Anderson Cancer Center
Similarity Score15%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoproliferative DisordersLymphoma, Non-Hodgkin

Worked with same sponsors:

Johns Hopkins UniversityM.D. Anderson Cancer Center
Similarity Score11%

Gregory Reid, MSc, MBA

MethylGene Inc.

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Jun Mao, MD, MSCE

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related
14 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Ye Guo, MD

Fudan University

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02510417Phase 1PrincipalInvestigator

Allogeneic Virus-specific T Cell Lines (VSTs)

Viral Infections After HSCT
Completed
NCT02510404Phase 1PrincipalInvestigator

Multivirus-specific Cytotoxic T Lymphocytes (mCTL)

Refractory Viral Infections
Completed
NCT01945814Phase 1PrincipalInvestigator

Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL)

AdenovirusCMVEBV
Completed
NCT02057445Phase 1PrincipalInvestigator

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Hodgkins LymphomaLymphoproliferative DisorderNon-Hodgkins Lymphoma
Completed

All 4 trials loaded